Single-point assessment of warfarin use and risk of osteoporosis in elderly men

Journal of the American Geriatrics Society

Volumn 56, Issue 7, 2008, Pages 1171-1176

  Woo, Claudine ^a,d   Chang, Linda L ^a,b   Ewing, Susan K ^c   Bauer, Douglas C ^c  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d AMGEN INC   (United States)

Author keywords

BMD; Fractures; Men; Warfarin

Indexed keywords

COUMARIN; WARFARIN;

AGED; ARTICLE; BONE DENSITY; CLINICAL ASSESSMENT; CLINICAL TRIAL; COHORT ANALYSIS; CONFIDENCE INTERVAL; DRUG MONITORING; FOLLOW UP; FRACTURE; GERIATRIC CARE; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOLYSIS; OSTEOPOROSIS; PROSPECTIVE STUDY; SECONDARY ANALYSIS; SELF REPORT; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; UNITED STATES;

ABSORPTIOMETRY, PHOTON; AGED; ANTICOAGULANTS; BONE DENSITY; FOLLOW-UP STUDIES; FRACTURES, BONE; GERIATRIC ASSESSMENT; HEALTH STATUS; HUMANS; MALE; MULTICENTER STUDIES AS TOPIC; OSTEOPOROSIS; RISK FACTORS; WARFARIN;

EID: 48449095297     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2008.01786.x     Document Type: Article

References (24)

1. American Geriatrics Society Clinical Practice Committee. The use of oral anticoagulants (warfarin) in older people. American Geriatrics Society guideline. J Am Geriatr Soc 2000 48 : 224 227.
2. Goodman LS, Gilman A, Brunton LL et al. Goodman & Gilman's the Pharmacological Basis of Therapeutics. New York : McGraw-Hill, 2006.
3. Hirsh J, Dalen J, Anderson DR et al. Oral anticoagulants: Mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 2001 119 : 8S 21S.
4. Vermeer C, Jie KS, Knapen MH. Role of vitamin K in bone metabolism. Annu Rev Nutr 1995 15 : 1 22.
5. Hauschka PV, Lian JB, Cole DE et al. Osteocalcin and matrix Gla protein: Vitamin K-dependent proteins in bone. Physiol Rev 1989 69 : 990 1047.
6. Lian JB, Gundberg CM. Osteocalcin. Biochemical considerations and clinical applications. Clin Orthop Relat Res 1988, 267 291.
7. Price PA, Williamson MK. Effects of warfarin on bone. J Biol Chem 1981 256 : 12754 12759.
8. Price PA. Role of vitamin-K-dependent proteins in bone metabolism. Annu Rev Nutr 1988 8 : 565 583.
9. Shearer MJ. Vitamin K. Lancet 1995 345 : 229 234.
10. Shearer MJ. Role of vitamin K and Gla proteins in the pathophysiology of osteoporosis and vascular calcification. Curr Opin Clin Nutr Metab Care 2000 3 : 433 438.
11. Zittermann A. Effects of vitamin K on calcium and bone metabolism. Curr Opin Clin Nutr Metab Care 2001 4 : 483 487.
12. Koshihara Y, Hoshi K. Vitamin K2 enhances osteocalcin accumulation in the extracellular matrix of human osteoblasts in vitro. J Bone Miner Res 1997 12 : 431 438.
13. Caraballo PJ, Gabriel SE, Castro MR et al. Changes in bone density after exposure to oral anticoagulants: A meta-analysis. Osteoporos Int 1999 9 : 441 448.
14. Caraballo PJ, Heit JA, Atkinson EJ et al. Long-term use of oral anticoagulants and the risk of fracture. Arch Intern Med 1999 159 : 1750 1756.
15. Mamdani M, Upshur RE, Anderson G et al. Warfarin therapy and risk of hip fracture among elderly patients. Pharmacotherapy 2003 23 : 1 4.
16. Pilon D, Castilloux AM, Dorais M et al. Oral anticoagulants and the risk of osteoporotic fractures among elderly. Pharmacoepidemiol Drug Saf 2004 13 : 289 294.
17. Gage BF, Birman-Deych E, Radford MJ et al. Risk of osteoporotic fracture in elderly patients taking warfarin: Results from the national registry of atrial fibrillation 2. Arch Intern Med 2006 166 : 241 246.
18. Jamal SA, Browner WS, Bauer DC et al. Warfarin use and risk for osteoporosis in elderly women. Study of osteoporotic fractures research group. Ann Intern Med 1998 128 : 829 832.
19. Blank JB, Cawthon PM, Carrion-Petersen ML et al. Overview of recruitment for the osteoporotic fractures in men study (MrOS). Contemp Clin Trials 2005 26 : 557 568.
20. Orwoll E, Blank JB, Barrett-Connor E et al. Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study - a large observational study of the determinants of fracture in older men. Contemp Clin Trials 2005 26 : 569 585.
21. Cummings SR, Bates D, Black DM. Clinical use of bone densitometry: Scientific review. JAMA 2002 288 : 1889 1897.
22. Sanders KM, Pasco JA, Ugoni AM et al. The exclusion of high trauma fractures may underestimate the prevalence of bone fragility fractures in the community: The Geelong Osteoporosis Study. J Bone Miner Res 1998 13 : 1337 1342.
23. Piro LD, Whyte MP, Murphy WA et al. Normal cortical bone mass in patients after long term coumadin therapy. J Clin Endocrinol Metab 1982 54 : 470 473.
24. Resch H, Pietschmann P, Krexner E et al. Decreased peripheral bone mineral content in patients under anticoagulant therapy with phenprocoumon. Eur Heart J 1991 12 : 439 441.